I posted the highlights version of the interview which basically
covered what was going on with Mr. Ellison and Oracle but when you hear the entire interview you get a real glimpse of how he thinks and works and we haven’t heard a lot of that as this goes beyond the media coverage you normally hear. I like how he discusses the “cloud” technology and he’s right, it has been around forever and the opinion on how it became the buzzword we live by today is interesting.
Hardware is software he states and the complicated process is the software and he’s the “product guy” at Oracle. Oracle is not a consumer business but they sell to consumer oriented companies, like Apple. He’s been around for a long time and knows the players and their technologies. It’s humorous to hear him talk about SAP and how they admitted to stealing patented technology. “You want me to give HP advice”…classic and you have to hear the history he gives here. You can read about his NIH award from last year.
Larry Ellison Announced As Distinguished Medical Informatics Awardee for His Contributions to Health IT and the Ellison Foundation From the Friends of the National Library of Medicine (NIH)
He’s also part of the “Giving Pledge” along with Bill Gates, Warren Buffet and others.
The Giving Pledge Call for Philanthropy Continues to Grow–40 Billionaires Committed
He’s fascinated with technology and it shows how he tests limits. If you read the news in the last couple days, he has is own island now in 
Hawaii too. He has no limits:) When asked about his image that is projected in the media, he’s extremely funny and candid. He’s definitely one of a kind and has the left brain in gear and then some as he knows code as well as marketing and his company. It took 6 to 7 years to re-write all the Oracle applications for the cloud, so keep this in check when you think about how we function today and the amount of coding and development it takes to move to the cloud with applications. I said a while back when the President had his meetings with the brilliant men of code, he was there to learn, “aka men who write code”.
President Obama Meeting with Tech Industry Leaders–CEOs and Some of the Smartest CEOs (Algo Men) Who Write Code
He discusses “Workday” and and how Salesforce and many others use “Oracle” and how “Workday” doesn’t use one. He knows his engineering and infrastructure. In the question and answer session he is asked about what he is doing for healthcare and he talks about the Ellison Medical Foundation (and jokes about how long it took him to come up with that name) and how they are focused on “diseases related to aging” “for obvious reasons he states”..funny. The do both primary and applied research in this area with about a billion to support it. They are also simulating molecular computational control and building chemical simulators so they can design and test drugs.
Oracle is bringing back manufacturing to the US as well and he also brings up the shortage of engineers in America. He said we need engineers who are trained in the US to stay in the US and not leave
. He says it is madness that someone gets their PHD from Stanford and then get a note to “get out”. We don’t have enough “trained engineers” in the US and finishes up the interview by saying “it’s insane” what we do. I agree. Great interview and nice insight into what makes “Larry” tick..he’s one of most valuable “hybrid” personalities and individuals walking the earth today and he has logic, marketing, engineering and humor all wrapped into one.
I can hardly wait to see and hear what he does with his new island too:) BD
Perhaps more than any other tech figure in Silicon Valley, Larry Ellison — now also trying to become the proud owner of Hawaii’s Lanai — is, for lack of a better word, the man.
It’s a bit about endurance (he’s been at it since 1978, when he founded Oracle), a bit about success (the database giant still remains a very powerful force in the industry), a bit about spoiling for a fight (Hewlett-Packard, SAP, any small cloud company that irks him) and a lot about style (America’s Cup sailing, his gazillionaire Ironman persona and, for goodness sake, he is planning on buying an entire Hawaiian island, presumably for a lair). Ellison has the kind of long-term and powerful perspective that is rare in the app-happy Web 2.0 era of small ideas and too-big valuations.
http://allthingsd.com/20120621/larry-ellison-tells-it-like-it-is-the-full-d10-interview-video/?mod=tweet
there are other medical issues with hospitals cutting off vital drugs and limiting surgical procedures that are owned by the state. It continues on to talk about exhausted doctors and their lack of supplies as well. BD 
company using mRNA and back a couple years ago I interviewed the company and learned about their test that determines “cancer of the unknown primary” which means that cancer in the kidney for example may not really be kidney cancer but rather a cancer that originated in another part of the body and treatments are very specific today for cancer types. Medicare just announced a few days ago that they would cover Rosetta’s tests as well. BD 
She talks not only about the students but also about here feelings and dedication as head of the FDA. She commends community outreach programs. The concern for man and his fate she states is imperative. She did her medical residency in New York and served as the city’s health commissioner. She talks about the early days of AIDS and the need for integrated health services. 
in the fracture business, a sale of a subsidiary is required so Biomet will buy the DVR division. When you look at the overall price they are paying for Synthes, this seems like a drop in the bucket. BD
that a test called ocular pulse amplitude (OPA) can reliably detect carotid artery stenosis (CAS), a condition that clogs or blocks the arteries that feed the front part of the brain. It’s a known risk factor for stroke. 
“matched donors”. The institute also offers other cancer treatments to include leukemia, multiple myeloma and more. The patients participating in the trial will be those who have already tried conventional therapies and have not had a response. The trial page goes into detail as well about being a donor, the procedure and the 
inherited the same significant cancer resistance. The white blood cells of these mice were able to seek out and destroy cancer cells not only in cell cultures, but also in living mice. Dr. Cui designed a test to measure this Cancer-Killing Activity, called CKA, and used those cells from cancer resistant mice to cure other mice with cancer. Further investigation showed that high levels of CKA granulocytes were also found in the white blood cells of some healthy people, specifically in the immune systems of young healthy humans around the age of eighteen to twenty-five.
tissues while the other twin lies dormant. The standard therapy for treating metastatic tumors is chemotherapy. Chemotherapy will kill a certain number of tumor cells and those cells may shrink, so it will look as though you’re making progress, but with the immune system weak, the dormant twin can begin to form new tumors, which is why these cancers often return. 
The bad news here though is there may not be enough to go around for a while as there has been issues with production so it’s approved and hopefully this will be remedied shortly. Usually it’s been the generic cancer drugs that have been short for patients and not an expensive name brand. The FDA is also requesting that future lots also be approved as some of the cells used to produce the drug were growing too slow. Genentech is also working on a 3rd drug for HER2 breast cancer and recently reported some positive clinical trial results. BD 
with standard glucose readings and test results. It appears to be a pretty good cross section of patients who met the criteria and it is part of a larger data sharing project called the Virtual Data Warehouse. The HMO Research Network is a group of 19 healthcare organizations who agree to standardize data sets from EHRs to collaborate and who is behind the Data Warehouse. BD 
but there needs to be a little more data on side effects the article states. Sugar is sent from the body through urination which doesn’t’ normally happen until high glucose levels are reached. J and J has filed for regulatory clearance to sell the drug in the US. 
obesity rates push the condition to epidemic levels, affecting nearly 347 million people worldwide. While 10 different types of drugs are sold to treat diabetes, physicians still struggle to control their patients’ blood-sugar levels. 
explained what this test is. You may have cancer in your lung for example, but it may not have originated there and this test will be able to identify if it by chance came from somewhere else in your body, which makes a huge difference with treatments as one medication that treats lung cancer may be quite different from one that treats let’s say kidney cancer for an example. Lab results can be done in 10 days or less. You can read my original interview below for more information. 
to help it explore "strategic options," including a possible sale of the company. 
but his creation of synthetic cells is all over the news from time to time. Juan states and emphasizes how “fast” this is all moving and it really is. Actually back in December of 2010, this was the big announcement made by Venter and he too is a guest on several of the TED conventions. The group also includes current NIH Director, Francis Collins when it comes to “cracking the code”. 
model it with math and computer code. This is not a new idea as Bill Gates invested in a company a couple years ago, Schrodinger, that does just that. A lot of work can be done on computers before a “wet lab” is ever set up. As she states, this will not give us all the answers but we have the potential of having a lot more information up front using math if we use it. 
from GlaxoSmithkline, dabrafenib , was tested against chemotherapy among 345 patients with inoperable late-stage melanomas and it also targets the BRAF gene. It stopped growth for around half of those taking it. There could be a potential of combining both dabrafenib and trametinib for a potential therapy. 
remission, it can return. The reason for this is under debate, and much is unclear. New research led by Weizmann Institute scientists shows that, at least for one type of blood cancer, the source of cancer recurrence is in a set of cells that do not proliferate as quickly as regular cancer cells, and thus are able to survive chemotherapy. The findings, which appear in the journal Blood, have some important implications for the future of the war on cancer. 
remote video consultations between a patient and doctor through a virtual face-to-face video interface, over a secure video network. Users of the service have the ability to conduct telepresence-quality face-to-face interactions over the Internet using existing laptops, smartphones or tablets – making it a very affordable and accessibly solution for patients, doctors and healthcare providers. 
the medical need for the medical marijuana which is pretty much uniform in all states where it is legal. We have pot cards in California for example. I wonder how long before the feds kick in here and stop the crazy battle that still exists over whether or not it is legal or not. Maybe we need a few more states to join in? BD